Inhibitors of Human Immunodeficiency Virus Integrase

Advances in Virus Research

Volumn 52, Issue C, 1999, Pages 427-458

  Pommier, Yves ^a   Neamati, Nouri ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; INTEGRASE INHIBITOR; VIRUS DNA;

ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; REVIEW; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; BINDING SITES; DNA, VIRAL; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HUMANS; MOLECULAR STRUCTURE; VIRUS INTEGRATION;

EID: 0032611358     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)60310-3     Document Type: Article

References (150)

1. Varmus, H., Brown, P., Retroviruses. Berg, D., Howe, M., (eds.) Mobile DNA, 1989, Am. Soc. Microbiol., Washington, DC, 53–108.
2. Katz, R.A., Skalka, A.M., The retroviral enzymes. Annu. Rev. Biochem. 63 (1994), 133–173.
3. Brown, P.O., Integration. Coffin, J.M., Hughes, S.H., Varmus, H.E., (eds.) Retroviruses, 1998, Cold Spring Harbor Press, Cold Spring Harbor, N.Y., 161–203.
4. Chow, S.A., In vitro assays for activities of retroviral integrase. Methods: Companion to Methods Enzymol. 12 (1997), 306–317.
5. Mazumder, A., Neamati, N., Sunder, S., Owen, J., Pommier, Y., Retroviral integrase: A novel target in antiviral development; basic in vitro assays with the purified enzyme. Kinchington, D., Schinazi, R., (eds.) Methods in Cellular and Molecular Biology: Antiviral Evaluation, 1998, Humana Press, Totowa, NJ.
6. Asante-Appiah, E., Skalka, A.M., Molecular mechanisms in retrovirus DNA integration. Antiviral Res. 36 (1997), 139–156.
7. Pommier, Y., Pilon, A.A., Bajaj, K., Mazumder, A., Neamati, N., HIV-1 integrase as a target for antiviral drugs. Antiviral Chem. Chemother. 8 (1997), 463–483.
8. Neamati, N., Sunder, S., Pommier, Y., Design and discovery of HIV-1 integrase inhibitors. Drug Discovery Today 2 (1997), 487–498.
9. Kulkosky, J., Skalka, A.M., HIV DNA integration: observations and inferences. J. Acquired Immune Deficiency Syndr. 3 (1990), 839–851.
10. Mazumder, A., Pommier, Y., Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type I integrase. Nucleic Acids Res. 23 (1995), 2865–2871.
11. Vink, C, van Gent, D.C., Elgersma, Y., Plasterk, R.H.A., Human immunodeficiency virus integrase protein requires a subterminal position for its viral DNA recognition sequence for efficient cleavage. J. Virol. 65 (1991), 4636–4644.
12. Katzman, M., Sudol, M., Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/Visna virus chimeric proteins. J. Virol. 72 (1998), 1744–1753.
13. Katzman, M., Sudol, M., Influence of subterminal viral DNA nucleotide on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. J. Virol. 70 (1996), 9069–9073.
14. White, S., Szewczyk, J.W., Turner, J.M., Baird, E.E., Dervan, P.B., Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature (London) 391 (1998), 468–470.
15. Neamati, N., Mazumder, A., Sunder, S., Owen, J.M., Tandon, M., Lown, J.W., Pommier, Y., Highly potent synthetic polyamines, bisdistamycins and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase. Mol. Pharmacol. 54 (1998), 280–290.
16. Mouscadet, J.-F., Carteau, S., Goulaouic, H., Subra, F., Auclair, C., Triplex-mediated inhibition of HIV DNA integration in vitro. J. Biol. Chem. 269 (1994), 21634–21638.
17. Mouscadet, J.-F., Ketterlé, C., Goulaouic, H., Carteau, S., Subra, F., Le Bret, M., Auclair, C., Triple helix formation with short oligonucleotide-intercalator conjugates matching the HIV-1 U3 LTR end sequence. Biochemistry 33 (1994), 4187–4196.
18. Ellison, V., Brown, P.O., A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc. Natl. Acad. Sci. U.S.A. 91 (1994), 7316–7320.
19. Pemberton, I.K., Buc, H., Buckle, M., Displacement of viral DNA termini from stable HIV-1 integrase nucleoprotein complexes induced by secondary DNA-binding interactions. Biochemistry 37 (1998), 2682–2690.
20. Wolfe, A.L., Felock, P.J., Hastings, H.C., Uncapher Blau, C., Hazuda, D., The role of manganese in promoting multimerization and assembly of human immunodeficiency type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates. J. Virol. 70 (1996), 1424–1432.
21. Ellison, V., Vincent, K.A., Brown, P.O., Characterization of a stable HIV integrase-viral DNA complex: an early intermediate in the integration pathway. J. Cell. Biochem., 18B, 1994, 19.
22. Ellison, V., Abrams, H., Roe, T., Lifson, J., Brown, P., Human immunodeficiency in a cell-free system. J. Virol. 64 (1990), 2711–2715.
23. Heuer, T.S., Brown, P.O., Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. Biochemistry 36 (1997), 10655–10665.
24. Jenkins, T.M., Esposito, D., Engelman, A., Craigie, R., Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J. 16 (1997), 6849–6859.
25. Drake, R., Neamati, N., Hong, H., Pilon, A.A., Sunthankar, P., Hume, S.D., Milne, G.W.A., Pommier, Y., Identification of a nucleotide binding site in HIV-1 integrase. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 4170–4175.
26. Mazumder, A., Neamati, N., Ojwang, J.O., Sunder, S., Rando, R.F., Pommier, Y., Inhibition of human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 43 (1996), 13762–13771.
27. Ojwang, J.O., Buckheit, R.W., Pommier, Y., Mazumder, A., De Vreese, K., Esté, J.A., Reymen, D., Pallansch, L.A., Lackman-Smith, C., Wallace, T.L., De Clercq, E., McGrath, M.S., Rando, R.F., T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 39 (1995), 2426–2435.
28. Mazumder, A., Cooney, D., Agbaria, R., Gupta, M., Pommier, Y., Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymi-dylate. Proc. Natl. Acad. Sci. U.S.A. 91 (1994), 5771–5775.
29. Lipford, J.R., Worland, S.T., Farnet, C.M., Nucleotide binding by the HIV-1 integrase protein in vitro. J. AIDS 7 (1994), 1215–1223.
30. Mazumder, A., Neamati, N., Sommadossi, J.-P., Gosselin, G., Schinazi, R., Imbach, J.-L., Pommier, Y., Effects of nucleotide analogs on human immunodeficiency virus type 1 integrase. Mol. Pharmacol. 49 (1996), 621–628.
31. Mazumder, A., Uchida, H., Neamati, N., Sunder, S., Jaworska-Maslanka, M., Wickstrom, E., Zeng, F., Jones, R.A., Mandes, R.F., Chenault, H.K., Pommier, Y., Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides. Mol. Pharmacol. 51 (1997), 567–575.
32. Cushman, M., Sherman, P., Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 185 (1992), 85–90.
33. Cushman, M., Golebiewski, W.M., Pommier, Y., Mazumder, A., Reymen, D., De Clercq, E., Grahm, L., Rice, W.G., Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 38 (1995), 443–452.
34. Carteau, S., Mouscadet, J.-F., Goulaouic, H., Subra, F., Auclair, C., Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 305 (1993), 606–610.
35. Nicklaus, M., Neamati, N., Hong, H., Mazumder, A., Sunder, Y., Chen, J., Milne, G.W.A., Pommier, Y., HIV-1 integrase pharmacophore: Discovery of inhibitors through 3D database searching. J. Med. Chem. 40 (1997), 920–929.
36. Hazuda, D., Felock, P., Hastings, J., Pramanik, B., Wolfe, A., Goodarzi, G., Vora, A., Brackmann, K., Grandgenett, D., Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds. J. Virol. 71 (1997), 807–811.
37. Engelman, A., Mizuuchi, K., Craigie, R., HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell (Cambridge, Mass.) 67 (1991), 1211–1221.
38. Vink, C., Yeheskiely, E., van der Marel, G.A., Van Boom, J.H., Plasterk, R.H.A., Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res. 19 (1991), 6691–6698.
39. Katzman, M., Sudol, M., Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases. J. Virol. 70 (1996), 2598–2604.
40. Fesen, M.R., Kohn, K.W., Leteurtre, F., Pommier, Y., Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 2399–2403.
41. Fesen, M.R., Pommier, Y., Leteurtre, F., Hiroguchi, S., Yung, J., Kohn, K.W., Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48 (1994), 595–608.
42. Chow, S.A., Vincent, K.A., Ellison, V., Brown, P.O., Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255 (1992), 723–726.
43. Roe, T., Chow, S.A., Brown, P.O., 3′-End processing and kinetics of 5′-end joining during retroviral integration in vivo. J. Virol. 71 (1997), 1334–1340.
44. Acel, A., Udashkin, B.E., Wainberg, M.A., Faust, E.A., Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase. J. Virol. 72 (1998), 2062–2071.
45. Farnet, C.M., Wang, B., Lipford, J.R., Bushman, F.D., Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 9742–9747.
46. Miller, M.D., Farnet, C.M., Bushman, F.D., Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71 (1997), 5382–5390.
47. Bukrinsky, M.I., Haggerty, S., Dempsey, M.P., Sharova, N., Adzhubel, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., Stevenson, M., A nuclear localization signal within HIV-1 matrix protein that governs infection of nondividing cells. Nature (London) 365 (1993), 666–669.
48. Freed, E.O., Martin, M.A., HIV-1 infection ofnon-dividing cells. Nature (London) 369 (1994), 107–108.
49. Freed, E.O., Englund, G., Maldarelli, F., Martin, M.A., Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell (Cambridge, Mass.) 88 (1997), 171–174.
50. Divita, G., Baillon, J.G., Rittinger, K., Chermann, J.-C., Goody, R.S., Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors. J. Biol. Chem. 270 (1995), 28642–28646.
51. Bukrinsky, M., Inhibitors of the nuclear translocation of the HIV-1 preintegration complex. Drugs Future 22 (1997), 875–883.
52. Dubrovsky, L., Ulrich, P., Nuovo, G.J., Manogue, K.R., Cerami, A., Bukrinsky, M., Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. Mol. Med. 1 (1995), 217–230.
53. Papov, S., Rexach, M., Zybarth, G., Reiling, N., Lee, M.-A., Ratner, L., Lane, C.M., Moore, M.S., Blobel, G., Bukrinsky, M., Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17 (1998), 909–917.
54. Wolff, B., Sanglier, J.J., Wang, Y., Leptomycin B is an inhibitor of nuclear export: Inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4 (1997), 139–147.
55. 2+-dependent 3′-processing activity of human immunodeficiency virus type 1 integrase in vitro. Biochemistry 36 (1996), 173–180.
56. Zheng, R., Jenkins, T.M., Craigie, R., Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 13659–13664.
57. 2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 36 (1997), 173–180.
58. Bushman, F.D., Engelman, A., Palmer, I., Wingfield, P., Craigie, R., Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 3428–3432.
59. Vink, C., Oude Groeneger, A.A.M., Plasterk, R.H.A., Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res. 21 (1993), 1419–1425.
60. Rice, W.G., Turpin, J.A., Virus-encoded zinc fingers as targets for antiviral chemotherapy. Rev. Med. Virol. 6 (1996), 187–199.
61. Khan, E., Mack, J.P., Katz, R.A., Kulkosky, J., Skalka, A.M., Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res. 19 (1991), 851–860 errata: Nucleic Acids Res., p. 1358.
62. La Femina, R.L., Schneider, C.L., Robbins, H.L., Callahan, P.L., Le Grow, K., Roth, E., Schleif, W.A., Emini, E.A., Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 66 (1992), 7414–7419.
63. Engelman, A., Craigie, R., Identification of conserved amino acid residues critical for human immunodeficiency virus type I integrase function in vitro. J. Virol. 66 (1992), 6361–6369.
64. Van Gent, D.C., Oude Groeneger, A.A.M., Plasterk, R.H.A., Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 9598–9602.
65. Bizub-Bender, D., Kulkosky, J., Skalka, A.M., Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure. AIDS Res. Hum. Retrovirus 10 (1994), 1105–1115.
66. Nilsen, B.M., Haugan, I.R., Berg, K., Olsen, L., Brown, P.O., Helland, D.E., Monoclonal antibodies against human immunodeficiency virus type 1 integrase: Epitope mapping and differential effects on integrase activities in vitro. J. Virol. 70 (1996), 1580–1587.
67. Barsov, E.V., Huber, W.E., Marcotrigiano, J., Clark, P.K., Clark, A.D., Arnold, E., Hughes, S.H., Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions. J. Virol. 70 (1996), 4484–4494.
68. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C., Pawson, T., SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252 (1991), 668–674.
69. Grzesiek, S., Bax, A., Clore, M., Gronenborn, A.M., Hu, J.-S., Kaufman, J., Palmer, I., Stahl, S.J., Wingfield, P.T., The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 3 (1996), 340–345.
70. Smithgall, T.E., SH2 and SH3 domains: Potential targets for anti-cancer drug design. J. Pharmacol. Toxicol. Methods 34 (1995), 125–132.
71. Morken, J.P., Kapoor, T.M., Feng, S., Shirai, F., Schreiber, S.L., Exploring the leucine-proline binding pocket of the src SH3 domain using structure-based, split-pool synthesis and affinity-based selection. J. Am. Chem. Soc. 120 (1998), 30–36.
72. Kapoor, T.M., Andreotti, A.H., Schreiber, S.L., Exploring the specificity pockets of two homologous SH3 domains using structure-based, split-pool synthesis and affinity-based selection. J. Am. Chem. Soc. 120 (1998), 23–29.
73. Vink, C., Lutzke, R.A.P., Plasterk, R.H.A., Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. Nucleic Acids Res. 22 (1994), 4103–4110.
74. Asante-Appiah, E., Skalka, A.M., A metal-induced conformational change and activation of HIV-1 integrase. J. Biol. Chem. 272 (1997), 16196–16205.
75. 2+-dependent 3′-processing activity for human immunodeficiency virus type 1 integrase in vitro: Real-time kinetic studies using fluorescence resonance energy transfer. Biochemistry 34 (1995), 10205–10214.
76. Engelman, A., Craigie, R., Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J. Virol. 69 (1995), 5908–5911.
77. Bujacz, G., Alexandratos, J., Wlodawer, A., Merkel, G., Andrake, M., Katz, R.A., Skalka, A.M., Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J. Biol. Chem. 272 (1997), 18161–18168.
78. Bujacz, G., Alexandratos, J., Qing, Z.L., Clement-Mella, C., Wlodawer, A., The catalytic domain of human immunodeficiency virus integrase: Ordered active site in the F185H mutant. FEBS Lett. 398 (1996), 175–178.
79. Yang, W., Steitz, T.A., Recombining the structures of HIV integrase, RuvC and RNase H. Curr. Biol. 3 (1995), 131–134.
80. Fletcher, T.M.I., Soares, M.A., McPhearson, S., Hui, H., Wiskerchen, M., Muesing, M.A., Shaw, G.M., Leavitt, A.D., Boeke, J.D., Hahn, B.H., Complementation of integrase function in HIV-1 virions. EMBO J. 16 (1997), 5123–5138.
81. Kalpana, G.V., Marmon, S., Wang, W., Crabtree, G.R., Goff, S.P., Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266 (1994), 2002–2006.
82. Morozov, A., Yung, E., Kalpana, G.V., Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 1120–1125.
83. Gallay, P., Swingler, S., Song, J., Bushman, F., Trono, D., HIV nuclear import is governed by the phophotyrosine-mediated binding of the matrix to the core domain of integrase. Cell (Cambridge, Mass.) 83 (1995), 569–576.
84. Schramm, H.J., Boetzel, J., Buttner, J., Fritsche, E., Gohring, W., Jaeger, E., Konig, S., Thumfart, O., Wenger, T., Nagel, N.E., Schramm, W., The inhibition of human immunodeficiency virus proteases by interface peptides. Antiviral Res. 30 (1996), 155–170.
85. Quere, L., Wenger, T., Schramm, H.J., Triterpenes as potential dimerization inhibitoon of HIV-1 protease. Biochem. Biophys. Res. Commun. 227 (1996), 484–488.
86. McPhee, F., Good, A.C., Kuntz, I.D., Craik, C.S., Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 11477–11481.
87. Feinberg, M.B., Trono, D., Intracellular immunization-transdominant mutants of HIV gene-products as tools for the study and interruption of viral replication. AIDS Res. Hum. Retroviruses 8 (1992), 1013–1022.
88. Babe, L.M., Rose, J., Craik, C.S., Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation. Proc. Natl. Acad. Sci. U.S.A. 92 (1995), 10069–10073.
89. Junker, U., Escaich, S., Plavec, I., Baker, J., McPhee, F., Rose, J.R., Craik, C.S., Bohnlein, E., Intracellular expression of human immunodeficiency virus type 1(HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines. J. Virol. 70 (1996), 7765–7772.
90. Smythe, J., Sun, D., Thomson, M., Markham, P., Reitz, M.S.J., Gallo, R.C., Lisziewicz, J., A Rev-inducible mutant gag gene stably transferred into T lymphocytes: An approach to gene therapy against human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 91 (1994), 3657–3661.
91. Zhang, Z.Y., Poorman, R.A., Maggiora, L.L., Heinrikson, R.L., Kezdy, F.J., Dissociative inhibition of dimeric enzymes: Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J. Biol. Chem. 266 (1991), 15591–15594.
92. Babe, L.M., Rose, J., Craik, C.S., Synthetic “interface” peptides alter dimeric assembly of the HIV 1 and 2 proteases. Protein Sci. 1 (1992), 1244–1253.
93. Hazuda, D., Felock, P.J., Hastings, J.C., Pramanik, B., Wolfe, A.L., Discovery and analysis of inhibitors of the human immunodeficiency integrase. Drug Des. Discovery 15 (1997), 17–24.
94. Sherman, P.A., Fyfe, J.A., Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc. Natl. Acad. Sci. U.S.A. 87 (1990), 5119–5123.
95. Craigie, R., Mizuuchi, K., Bushman, F.D., Engelman, A., A rapid in vitro assay for HIV DNA integration. Nucleic Acids Res. 19 (1991), 2729–2734.
96. Katzman, M., Katz, R.A., Skalka, A.M., Leis, J., The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63 (1989), 5319–5327.
97. Brown, P.O., Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 157 (1990), 19–48.
98. La Femina, R.L., Callahan, P.L., Cordingley, M.G., Substrate specificity of recombinant human immunodeficiency virus integrase protein. J. Virol. 65 (1991), 5624–5630.
99. Leavitt, A.D., Rose, R.B., Varmus, H.E., Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in. Saccharomyces cerevisiae. J. Virol. 66 (1992), 2359–2368.
100. Van Gent, D.C., Elgersma, Y., Bolk, M.W., Vink, C., Plasterk, R.H.A., DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Res. 19 (1991), 3821–3827.
101. Müller, B., Jones, K.S., Merkel, G.W., Skalka, A.M., Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 11633–11637.
102. Vink, C., Banks, M., Bethell, R., Plasterk, R.H.A., A high-throughput, non-radioactive microtiter plate assay for activity of the human immnodeficiency virus integrase protein. Nucleic Acids Res. 22 (1994), 2176–2177.
103. Hazuda, D.J., Hastings, J.C., Wolfe, A.L., Emini, E.A., A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Res. 22 (1994), 1121–1122.
104. Chang, Y.C., Ching, T.T., Syu, W.J., Assaying the activity of HIV-1 integrase with DNA-coated plates. J. Virol. Methods 59 (1996), 135–140.
105. Bushman, F.D., Fujiwara, T., Craigie, R., Retroviral DNA integration directed by HIV integration protein in vitro. Science 249 (1990), 1555–1558.
106. Bushman, F.D., Craigie, R., Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 1339–1343.
107. Drelich, M., Wilhelm, R., Mous, J., Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 protein in vitro. Virology 188 (1992), 459–468.
108. Lee, S.P., Censullo, M.L., Kim, H.G., Han, M.K., Substrate-length-dependent activities of human immunodeficiency type 1 integrase in vitro: Differential DNA binding affinities associated with different lenghths of substrates. Biochemistry 34 (1995), 10215–10223.
109. Raghavan, K., Buolamwini, J.K., Fesen, M.R., Pommier, Y., Kohn, K.W., Weinstein, J.N., Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: A comparative molecular field analysis (CoMFA) study. J. Med. Chem. 38 (1995), 890–897.
110. Neamati, N., Hong, H., Sunder, S., Milne, G.W.A., Pommier, Y., Potent inhibitors of human immunodeficiency virus type 1 integrase: Identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors. Mol. Pharmacol. 52 (1997), 1041–1055.
111. Hong, H., Neamati, N., Wang, S., Nicklaus, M., Mazumder, A., Zhao, H., Burke, T.R., Pommier, Y., Milne, G.W.A., Discovery of human immunodeficiency virus type 1 integrase inhibitors by pharmacophore searching. J. Med. Chem. 40 (1997), 930–936.
112. Burke, T.R., Fesen, M., Mazumder, A., Yung, J., Wang, J., Carothers, A.M., Grunberger, D., Driscoll, J., Pommier, Y., Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem. 38 (1995), 4171–4178.
113. Zhao, H., Neamati, N., Hong, H., Mazumder, A., Wang, S., Sunder, S., Milne, G.W.A., Pommier, Y., Burke, T.R. Jr., Coumarin-based inhibitors of HIV integrase. J. Med. Chem. 40 (1996), 242–249.
114. Zhao, H., Neamati, N., Mazumder, A., Sunder, S., Pommier, Y., Burke, T., Arylamide inhibitors of HIV-1 integrase. J. Med. Chem. 40 (1997), 1186–1194.
115. Zhao, H., Neamati, N., Sunder, S., Hong, H., Wang, S., Milne, G.W.A., Pommier, Y., Burke, T., Hydrazine-containing inhibitors of HIV-1 integrase. J. Med. Chem. 40 (1997), 937–941.
116. Mazumder, A., Neamati, N., Sunder, S., Schulz, J., Pertz, H., Eich, E., Pommier, Y., Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J. Med. Chem. 40 (1997), 3057–3063.
117. Lubkowski, J., Yang, F., Alexandratos, J., Wlodawer, A., Zhao, H., Burke, T.R., Neamati, N., Pommier, Y., Merkel, G., Skalka, A.M., Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 4831–4836.
118. Farnet, C.M., Bushman, F.D., HIV cDNA integration: Molecular biology and inhibitor development. AIDS 10:Suppl. A (1996), S3–S11.
119. Thomas, M., Brady, L., HIV integrase: A target for AIDS therapeutics. Trends Biotechnol. 15 (1997), 167–172.
120. Carteau, S., Mouscadet, J.-F., Goulaouic, H., Subra, F., Auclair, C., Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochem. Biophys. Res. Commun. 192 (1993), 1409–1414.
121. Hansen, M.S.T., Bushman, F.D., Human immunodeficiency virus type 2 preintegration complexes: Activities in vitro and response to inhibitors. J. Virol. 71 (1997), 3351–3356.
122. Mazumder, A., Gupta, M., Perrin, D.M., Sigman, D.S., Rabinovitz, M., Pommier, Y., Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: The phenanthroline-cuprous complex. AIDS Res. Hum. Retroviruses 11 (1995), 115–125.
123. Bouziane, M., Cherny, D.I., Mouscadet, J.-F., Auclair, C., Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro. J. Biol. Chem. 271 (1996), 10359–10364.
124. Ouali, M., Bouziane, M., Ketterle, C., Gabarro-Arpa, J., Auclair, C., Le Bret, M., A molecular mechanics and dynamics study of alternate triple-helices involving the integrase-binding site of the HIV-1 virus and oligonucleotides having a 3′-3′ internucleotide junction. J. Biomol. Struct. Dyn. 13 (1996), 835–853.
125. Carteau, S., Mouscadet, J.F., Goulaouic, H., Subra, F., Auclair, C., Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin. Biochem. Pharmacol. 47 (1994), 1821–1826.
126. Wang, W., Lown, L., Anti-HIV-1 activity of linked lexitropsins. J. Med. Chem. 35 (1992), 2890–2897.
127. Drake, R., Neamati, N., Sunthankar, P., Mazumder, A., Pommier, Y., Identification of the antiviral nucleoside drug binding site of HIV-1 integrase by proteolytic peptide mapping. Antiviral Res., 34, 1997, A42.
128. Allen, P., Worland, S., Gold, L., Isolation of high-affinity RNA ligands to HIV1 integrase from a random pool. Virology 209 (1995), 327–336.
129. Este, J.A., Cabrera, C., Schols, D., Cherepanov, P., Gutierrez, A., Witvrouw, M., Pannecouque, C., Debyser, Z., Rando, R.F., Clotet, B., Desmyter, J., De Clercq, E., Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). Mol. Pharmacol. 53 (1998), 340–345.
130. Mazumder, A., Gazit, A., Levitzki, A., Nicklaus, M., Yung, J., Kohlhagen, G., Pommier, Y., Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase. Biochemistry 34 (1995), 15111–15121.
131. Eich, E., Petz, H., Kaloga, M., Schulz, J., Fesen, M.R., Mazumder, A., Pommier, Y., (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem. 39 (1996), 86–95.
132. La Femina, R.L., Graham, P.L., Le Grow, K., Hastings, J.C., Wolfe, A., Young, S.D., Emini, E.A., Hazuda, D., Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 39 (1995), 320–324.
133. Robinson, W.E., Cordeiro, M., Abdel-Malek, S., Jia, Q., Chow, S.A., Reinecke, M.G., Mitchell, W.M., Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: Inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol. Pharmacol. 50 (1996), 846–855.
134. Neamati, N., Hong, H., Mazumder, A., Wang, S., Sunder, S., Nicklaus, M.C., Milne, G.W.A., Proska, B., Pommier, Y., Depside and depsidones as inhibitors of HIV-1 integrase: Discovery of novel inhibitors through 3D database searching. J. Med. Chem. 40 (1997), 942–951.
135. Robinson, W.E., Reinecke, M.G., Abdel-Malek, S., Jia, Q., Chow, S.A., Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 6326–6331.
136. Stanwell, C., Ye, B., Yuspa, S.H., Burke, T.R., Cell protein-crosslinking by erbstatin and related compounds. Biochem. Pharmacol. 52 (1996), 475–480.
137. Rice-Evans, C., Plant polyphenols: Free radical scavenger or chain-breaking antioxidants?. Biochem. Soc. Symp. 61 (1995), 103–116.
138. Mahmood, N., Piacente, S., Pizza, C., Burke, A., Khan, A.I., Hay, A.J., The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena. Biochem. Biophys. Res. Commun. 229 (1996), 73–79.
139. Critchfield, J.W., Butera, S.T., Folks, T.M., Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res. Hum. Retroviruses 12 (1996), 39–46.
140. Mazumder, A., Raghavan, K., Weinstein, J., Kohn, K.W., Pommier, Y., Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem. Pharmacol. 49 (1995), 1165–1170.
141. Mazumder, A., Wang, S., Neamati, N., Nicklaus, M., Sunder, S., Chen, J., Milne, G., Rice, W.G., Burke, T.R., Pommier, Y., Antiretroviral agent as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J. Med. Chem. 39 (1996), 2472–2481.
142. Zhao, H., Neamati, N., Pommier, Y., Burke, T.R., Design and synthesis of photoactivatable coumarin-containing HIV-1 integrase inhibitors. Heterocycles 45 (1997), 2277–2282.
143. Neamati, N., Hong, H., Owen, J.M., Sunder, S., Winslow, H.E., Christensen, J.L., Zhao, H., Burke, J.T.R., Milne, G.W.A., Pommier, Y., Salicylhydrazinecontaining inhibitors of HIV-1 integrase: Implication for a selective chelation in the integrase active site. J. Med. Chem. 41 (1998), 3202–3209.
144. Billich, A., Schauer, M., Frank, S., Rosenwirth, B., Billich, S., HIV-1 integrase: High-level production and screening assay for the endonucleolytic activity. Antiviral Chem. Chemother. 3 (1992), 113–119.
145. Neamati, N., Mazumder, A., Zhao, H., Sunder, S., Burke, T.R., Schultz, R.J., Pommier, Y., Diarylsulfones, a novel class of HIV-1 integrase inhibitors. Antimicrobiol. Agents Chemother. 41 (1997), 385–393.
146. Neamati, N., Mazumder, A., Sunder, S., Owen, J.M., Schultz, R.J., Pommier, Y., 2-Mercaptobenzenesulfonamides as novel inhibitors of human immunodeficiency virus type 1 integrase and replication. Antiviral Chem. Chemother. 8 (1997), 485–495.
147. Lutzke, R.A.P., Eppens, N.A., Weber, P.A., Houghten, R.A., Plasterk, R.H.A., Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc. Natl. Acad. Sci. U.S.A. 92 (1995), 11456–11460.
148. Sourgen, F., Maroun, R.G., Frere, V., Bouziane, M., Auclair, C., Troalen, F., Fermandjian, S., A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results. Eur. J. Biochem. 240 (1996), 765–773.
149. Cannon, P.M., Wilson, W., Byles, E., Kingsman, S.M., Kingsman, A.J.K., Human immunodeficiency virus type 1 integrase: Effect on viral replication of mutation at hightly conserved residues. J. Virol. 68 (1994), 4768–4775.
150. Levy-Mintz, P., Duan, L., Zhang, H., Hu, B., Dornadula, G., Zhu, M., Kulkosky, J., Bizub-Bender, D., Skalka, A.M., Pomerantz, R.J., Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J. Virol. 70 (1996), 8821–8832.